175 related articles for article (PubMed ID: 6988470)
1. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
Edelson RL
J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
[TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998-2016.
Keto J; Hahtola S; Linna M; Väkevä L
BMC Health Serv Res; 2021 Feb; 21(1):166. PubMed ID: 33618714
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2016 Jan; 91(1):151-65. PubMed ID: 26607183
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.
Geskin LJ; Akilov OE; Kwon S; Schowalter M; Watkins S; Whiteside TL; Butterfield LH; Falo LD
Cancer Immunol Immunother; 2018 Mar; 67(3):423-434. PubMed ID: 29204699
[TBL] [Abstract][Full Text] [Related]
5. The biomarker landscape in mycosis fungoides and Sézary syndrome.
Dulmage B; Geskin L; Guitart J; Akilov OE
Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal changes and functional alterations of T-cell substates gene expression during the progression of mycosis fungoides.
Dong Z; Zhu X; Pan X; Su Q; Wang F
Arch Dermatol Res; 2024 May; 316(6):207. PubMed ID: 38787417
[No Abstract] [Full Text] [Related]
7. Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome.
Levy Yurkovski I; Rokach L; Melamed G; Alapi H; Gazit S; Patalon T; Tadmor T
Acta Haematol; 2023; 146(6):496-503. PubMed ID: 37517402
[TBL] [Abstract][Full Text] [Related]
8. Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.
Abrams JT; Vonderheid EC; Kolbe S; Appelt DM; Arking EJ; Balin BJ
Clin Diagn Lab Immunol; 1999 Nov; 6(6):895-905. PubMed ID: 10548583
[TBL] [Abstract][Full Text] [Related]
9. Reply to letter to the editor (Manuscript # JAAD-D-22-03011R1).
LeWitt TM; Walker CJ; Espinosa ML; Chung C; Zhou XA; Guitart J
J Am Acad Dermatol; 2023 Jul; 89(1):e67. PubMed ID: 36948297
[No Abstract] [Full Text] [Related]
10. Prevalence and implications of mogamulizumab-induced immune-related adverse events in mycosis fungoides/Sézary syndrome; a single-center experience.
Jfri A; Virgen CA; Tawa M; Giobbie-Hurder A; Kupper TS; Fisher DC; LeBoeuf NR; Larocca C
J Am Acad Dermatol; 2023 Nov; 89(5):1044-1047. PubMed ID: 37321484
[No Abstract] [Full Text] [Related]
11. Influence of medical comorbidities, smoking, and alcohol on mycosis fungoides progression and mortality.
Fakhoury JW; Buechler CR; Veenstra J
Int J Dermatol; 2024 Feb; 63(2):e33-e35. PubMed ID: 37997446
[No Abstract] [Full Text] [Related]
12. Staphylococcus aureus and Sézary syndrome.
Merlio JP
Blood; 2024 Apr; 143(15):1436-1438. PubMed ID: 38602696
[No Abstract] [Full Text] [Related]
13. Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells.
Brouwer IJ; Out-Luiting JJ; Vermeer MH; Tensen CP
Biochem Biophys Rep; 2020 Dec; 24():100832. PubMed ID: 33102814
[TBL] [Abstract][Full Text] [Related]
14. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma.
Adachi T; Kobayashi T; Sugihara E; Yamada T; Ikuta K; Pittaluga S; Saya H; Amagai M; Nagao K
Nat Med; 2015 Nov; 21(11):1272-9. PubMed ID: 26479922
[TBL] [Abstract][Full Text] [Related]
15. Dermatology-epitomes of progress: new developments in the staging and therapy of mycosis fungoides.
Price NM
West J Med; 1981 Jan; 134(1):48-9. PubMed ID: 18748769
[No Abstract] [Full Text] [Related]
16. The behavior of epidermotropic lymphoma in twenty-five dogs.
Wilcock BP; Yager JA
Can Vet J; 1989 Sep; 30(9):754-6. PubMed ID: 17423425
[No Abstract] [Full Text] [Related]
17. Improved generation of anti-tumor immunity by antigen dose limitation.
Shofner JD; Vasquez JG; Berger CL; Edelson RL
J Immune Based Ther Vaccines; 2007 Feb; 5():2. PubMed ID: 17291350
[TBL] [Abstract][Full Text] [Related]
18. Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins.
Lee M; Kistler C; Hartmann TB; Li F; Dummer R; Dippel E; Booken N; Klemke CD; Schadendorf D; Eichmüller SB
Cancer Immunol Immunother; 2007 Jun; 56(6):783-95. PubMed ID: 17089123
[TBL] [Abstract][Full Text] [Related]
19. Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading.
Salskov-Iversen M; Berger CL; Edelson RL
J Immune Based Ther Vaccines; 2005 Jul; 3():4. PubMed ID: 16029505
[TBL] [Abstract][Full Text] [Related]
20. p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides.
Navas IC; Ortiz-Romero PL; Villuendas R; Martínez P; García C; Gómez E; Rodriguez JL; García D; Vanaclocha F; Iglesias L; Piris MA; Algara P
Am J Pathol; 2000 May; 156(5):1565-72. PubMed ID: 10793068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
